AtriCure (ATRC)
(Delayed Data from NSDQ)
$22.05 USD
+1.01 (4.80%)
Updated Aug 2, 2024 04:00 PM ET
After-Market: $22.04 -0.01 (-0.05%) 7:58 PM ET
3-Hold of 5 3
C Value B Growth F Momentum C VGM
Price, Consensus and EPS Surprise
ATRC 22.05 +1.01(4.80%)
Will ATRC be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for ATRC based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for ATRC
AtriCure (ATRC) Reports Q2 Earnings: What Key Metrics Have to Say
AtriCure (ATRC) Reports Q2 Loss, Lags Revenue Estimates
ATRC: What are Zacks experts saying now?
Zacks Private Portfolio Services
AtriCure (ATRC) Gains China Approval for AtriClip LAA System
Abbott (ABT) Q2 Earnings and Revenues Top Estimates
Compared to Estimates, AtriCure (ATRC) Q1 Earnings: A Look at Key Metrics
Other News for ATRC
AtriCure Inc (ATRC) Q2 2024 Earnings Call Transcript Highlights: Strong Revenue Growth and ...
Atricure (ATRC) Gets a Buy from Oppenheimer
AtriCure price target lowered by $5 at BTIG, here's why
AtriCure price target lowered by $4 at Stifel, here's why
AtriCure’s Resilience Amidst Competition: A Strong Buy Recommendation